(Q37724704)

English

Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure

scientific article published on April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yang Zhang

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Xiao-Yu Hu

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Sen Zhong

3

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Fang Yang

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Tao-You Zhou

5

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Guo Chen

6

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Yan-Yan Wang

7

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Jian-Xing Luo

8

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

language of work or name

0 references

publication date

1 April 2014

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

16

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

4745-4752

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Adult-to-adult living donor liver transplantation for acute liver failure in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

Reassessing the role for lamivudine in chronic hepatitis B infection: a four-year cohort analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

AASLD position paper: the management of acute liver failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 August 2017

13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

6 September 2017

The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

6 September 2017

Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

14 September 2017

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

23 June 2018

T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

The impact of early rapid virological response on the outcomes of hepatitis B associated acute on chronic liver failure during antiviral treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

The study of efficacy of lamivudine in patients with severe acute hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Fulminant hepatic failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Viral dynamics in chronic hepatitis B patients during lamivudine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4000512

1 September 2018

Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Diagnostic and treatment guidelines for liver failure]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-on-chronic liver failure]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/24782628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V20.I16.4745

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37724704&oldid=1725664345"